Skip to content

Clinical trials

Small Cell Lung Carcinoma trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Country / region: Brazil Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20061
20101
20111
20121
20162
20173
20182
20191
20201
20221
20231
20244
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting7
Recruiting6
Approved for marketing1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen6
AbbVie4
Hoffmann-La Roche3
AstraZeneca2
Bristol-Myers Squibb2
GlaxoSmithKline2
PharmaMar2
Sanofi2
Boehringer Ingelheim1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma29
Lung Neoplasms4
Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Neoplasm Metastasis2
Bites and Stings1
Carcinoma, Hepatocellular1
Carcinoma, Transitional Cell1

Trials

Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.